Stockscreener 앱 받기
26.11
9.84%
-2.85
전일 마감가:
$28.96
열려 있는:
$29.21
하루 거래량:
1.02M
Relative Volume:
1.37
시가총액:
$742.24M
수익:
$30.43M
순이익/손실:
$-18.15M
주가수익비율:
-37.84
EPS:
-0.69
순현금흐름:
$-9.08M
1주 성능:
-4.64%
1개월 성능:
+147.96%
6개월 성능:
+134.17%
1년 성능:
+129.24%
1일 변동 폭
$26.01
$29.35
1주일 범위
$24.21
$30.10
52주 변동 폭
$9.76
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
명칭
Clearpoint Neuro Inc
전화
(949) 900-6833
주소
120 S. SIERRA AVENUE, SOLANA BEACH, CA
CLPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
26.11 | 823.26M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-25 | 재개 | B. Riley Securities | Buy |
| 2023-10-24 | 개시 | Stifel | Buy |
| 2023-02-16 | 재개 | B. Riley Securities | Buy |
| 2022-04-05 | 재개 | B. Riley Securities | Buy |
| 2021-03-18 | 개시 | Lake Street | Buy |
| 2020-07-17 | 개시 | B. Riley FBR | Buy |
모두보기
Clearpoint Neuro Inc 주식(CLPT)의 최신 뉴스
Can ClearPoint Neuro Inc. stock hit record highs againPortfolio Return Summary & AI Driven Stock Reports - newser.com
ClearPoint Neuro (NASDAQ:CLPT) Sets New 1-Year HighTime to Buy? - MarketBeat
What’s next for ClearPoint Neuro Inc. stock priceEarnings Performance Report & Precise Swing Trade Entry Alerts - newser.com
Combining machine learning predictions for ClearPoint Neuro Inc.July 2025 PostEarnings & Reliable Price Breakout Alerts - newser.com
ClearPoint Neuro's (CLPT) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Clearpoint Neuro, Inc. Hits New 52-Week High of $29.85 - Markets Mojo
ClearPoint Neuro (NASDAQ:CLPT) Trading Up 7.4%Should You Buy? - MarketBeat
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be presented at the CNS Annual Meeting in Los Angeles - MarketScreener
ClearPoint Neuro reports positive results from brain tumor laser therapy study - Investing.com Nigeria
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles - Stock Titan
ClearPoint Neuro expands regulatory approvals to 34 countries By Investing.com - Investing.com Nigeria
ClearPoint Neuro expands regulatory approvals to 34 countries - Investing.com
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide - ACCESS Newswire
34 Countries: ClearPoint Neuro Expands Regulatory Clearances with Canada, Hong Kong and Taiwan additions - Stock Titan
Clearpoint Neuro Reaches New 52-Week High of $28.80, Up 377% - Markets Mojo
CLPT Expands Into Robotic System Supporting Cell and Gene Therapies - The Globe and Mail
Will ClearPoint Neuro Inc. stock benefit from automationJuly 2025 Macro Moves & Reliable Price Breakout Signals - newser.com
Using RSI to spot recovery in ClearPoint Neuro Inc.Trade Volume Report & Real-Time Stock Price Movement Reports - newser.com
Using data models to predict ClearPoint Neuro Inc. stock movementSell Signal & Daily Growth Stock Investment Tips - newser.com
Will ClearPoint Neuro Inc. stock outperform value stocksQuarterly Market Review & Real-Time Stock Price Movement Reports - newser.com
Will ClearPoint Neuro Inc. stock beat EPS estimatesQuarterly Market Review & Real-Time Stock Price Movement Reports - newser.com
Can ClearPoint Neuro’s (CLPT) New Robotic Platform Redefine Its Clinical Expansion Trajectory? - Sahm
ClearPoint Neuro (NASDAQ:CLPT) Reaches New 12-Month High – Here’s What Happened - Defense World
ClearPoint Neuro (CLPT): Gauging Valuation After Robotic Innovation, Insider Buying, and Huntington’s Therapy Progress - Yahoo Finance
Stifel maintains Clearpoint Neuro stock Buy rating, $17 target - MSN
ClearPoint Neuro (CLPT): Evaluating Valuation After Dr. Paul Larson Announced as Incoming Chief Medical Officer - Sahm
ClearPoint Neuro adds to gains, up 125% since Sept 23 - TradingView
ClearPoint Neuro (NASDAQ:CLPT) Hits New 52-Week HighHere's What Happened - MarketBeat
ClearPoint Neuro: AMT-130 Highlights A Bright Future (NASDAQ:CLPT) - Seeking Alpha
ClearPoint Neuro (NASDAQ:CLPT) Trading Up 5.9%Still a Buy? - MarketBeat
ClearPoint Neuro developing robotic navigation system for brain surgeries - Investing.com
ClearPoint Neuro developing robotic navigation system for brain surgeries By Investing.com - Investing.com Australia
ClearPoint Neuro : Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System - MarketScreener
ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System - ACCESS Newswire
Revolutionary Robot-Guided Brain Navigation System: ClearPoint Neuro's New Platform for Gene Therapy Delivery - Stock Titan
Clearpoint Neuro, Inc. Hits New 52-Week High of $22.38 - Markets Mojo
Is ClearPoint Neuro Inc a good long term investmentSector ETF Performance & Access Powerful Market Insights - earlytimes.in
Full technical analysis of ClearPoint Neuro Inc. stockPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - newser.com
Clearpoint Neuro Inc (CLPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Clearpoint Neuro Inc 주식 (CLPT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Richards Timothy T. | Director |
Jun 10 '25 |
Sale |
13.28 |
10,000 |
132,800 |
77,381 |
| BURNETT JOSEPH | CEO and President |
Jun 09 '25 |
Sale |
13.29 |
21,247 |
282,373 |
243,522 |
1.83%
자본화:
|
볼륨(24시간):